DE69609501D1 - Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte - Google Patents

Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte

Info

Publication number
DE69609501D1
DE69609501D1 DE69609501T DE69609501T DE69609501D1 DE 69609501 D1 DE69609501 D1 DE 69609501D1 DE 69609501 T DE69609501 T DE 69609501T DE 69609501 T DE69609501 T DE 69609501T DE 69609501 D1 DE69609501 D1 DE 69609501D1
Authority
DE
Germany
Prior art keywords
sodium starch
starch glycolate
active substances
composition
basic material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69609501T
Other languages
English (en)
Other versions
DE69609501T2 (de
Inventor
Fabio Carli
J Shah
Edward C Shinal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptalis Pharma SRL
Original Assignee
Eurand International SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand International SpA filed Critical Eurand International SpA
Application granted granted Critical
Publication of DE69609501D1 publication Critical patent/DE69609501D1/de
Publication of DE69609501T2 publication Critical patent/DE69609501T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69609501T 1995-04-20 1996-04-17 Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte Expired - Lifetime DE69609501T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42543495A 1995-04-20 1995-04-20
PCT/IB1996/000492 WO1996032931A2 (en) 1995-04-20 1996-04-17 Composite with sodium starch glycolate as a support material and products thereof

Publications (2)

Publication Number Publication Date
DE69609501D1 true DE69609501D1 (de) 2000-08-31
DE69609501T2 DE69609501T2 (de) 2001-03-29

Family

ID=23686568

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609501T Expired - Lifetime DE69609501T2 (de) 1995-04-20 1996-04-17 Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte

Country Status (11)

Country Link
EP (1) EP0822808B1 (de)
JP (1) JPH11503749A (de)
AT (1) ATE194909T1 (de)
AU (1) AU5658496A (de)
CA (1) CA2218486A1 (de)
DE (1) DE69609501T2 (de)
DK (1) DK0822808T3 (de)
ES (1) ES2149471T3 (de)
GR (1) GR3034617T3 (de)
PT (1) PT822808E (de)
WO (1) WO1996032931A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
DE60205491T2 (de) * 2001-06-29 2006-06-01 Eurand Pharmaceuticals Ltd. Verfahren zur arzneimittelaktivierung mittels schwingmühle
NZ530827A (en) 2001-06-29 2005-06-24 Eurand Pharmaceuticals Ltd Process for activation of drugs in a vibrational mill
PT1558582E (pt) 2003-07-22 2006-05-31 Arena Pharm Inc Derivados de diaril- e aril-heteroaril-ureia como moduladores do receptor de serotonina 5-ht2a uteis para a profilaxia e tratamento de desordens relacionadas com o mesmo
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
ES2421237T7 (es) 2007-08-15 2013-09-30 Arena Pharmaceuticals, Inc. Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
PT2364142T (pt) 2008-10-28 2018-04-23 Arena Pharm Inc Composições de um modulador do recetor da serotonina 5-ht2a para o tratamento de distúrbios com ele relacionados
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
RU2017145976A (ru) 2015-06-12 2019-07-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
KR20180064373A (ko) 2015-07-15 2018-06-14 엑소반트 사이언시즈 게엠베하 신경퇴행성 질환과 관련된 환각의 예방 및 치료에 유용한 5-ht2a 세로토닌 수용체의 조절자로서의 다이아릴 및 아릴헤테로아릴 우레아 유도체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition

Also Published As

Publication number Publication date
CA2218486A1 (en) 1996-10-24
DE69609501T2 (de) 2001-03-29
EP0822808B1 (de) 2000-07-26
GR3034617T3 (en) 2001-01-31
ES2149471T3 (es) 2000-11-01
ATE194909T1 (de) 2000-08-15
DK0822808T3 (da) 2000-10-09
JPH11503749A (ja) 1999-03-30
AU5658496A (en) 1996-11-07
EP0822808A2 (de) 1998-02-11
WO1996032931A2 (en) 1996-10-24
WO1996032931A3 (en) 1996-11-28
PT822808E (pt) 2000-12-29

Similar Documents

Publication Publication Date Title
DE69609501D1 (de) Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte
UY24875A1 (es) Composiciones farmacéuticas conteniendo tetrahidrolipstatina
BG103862A (en) Compositions of derivatives of erythromycin with continuous release
AU7915898A (en) Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
AP1954A (en) Controlled release compositions comprising nimesulide.
AR017780A1 (es) Conjugado del factor de liberacion de hormona de crecimiento-polietilenenglicol (hgrf-peg) y metodo para la preparacion en sitio-especifico del mismo.
DE69433355D1 (de) Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate
BG103714A (en) Pararacetamol-containing tablet
AU7134898A (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
AU8025998A (en) Biologically active materials
IT1301968B1 (it) Derivati di eritromicina ad attivita' antibiotica
NZ515999A (en) Biologically active materials
AU5685300A (en) Solid preparations containing paroxetine
ES2165509T3 (es) Composiciones terapeuticas efervescentes.
FR2797446B1 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
WO1998036778A8 (en) Sustained drug delivery and compositions useful therefor
DE60324944D1 (de) Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin-antibiotikum
ES2082524T3 (es) Medicamento de liberacion retardada que contiene un derivado de dihidropiridina en forma de nanosol y su preparacion.
IL147900A0 (en) Ascididemin derivatives and their therapeutic applications
ECSP993215A (es) Nueva composicion y uso
ATE145334T1 (de) Onconase und cisplatin, melphalan und adriamycin enthaltende arzneimittel
ECSP993216A (es) Nueva composicion y uso ii
MX9705611A (es) Composiciones farmaceuticas en forma de tabletas de liberacion prolongada con base de granulos polisacaridos de alto peso molecular.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT

8364 No opposition during term of opposition
R081 Change of applicant/patentee

Ref document number: 822808

Country of ref document: EP

Owner name: APTALIS PHARMA S.R.L., IT

Free format text: FORMER OWNER: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT

Effective date: 20110824

R082 Change of representative

Ref document number: 822808

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE

R082 Change of representative

Ref document number: 822808

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE